Dangers of Type 2 Diabetes Medication
Type 2 diabetes affects almost 10% of the American population and that number grows by nearly 2 million ever year. Unfortunately, many pharmaceutical companies see your diagnosis as a financial opportunity. Manufacturers rush drugs to market without rigorous testing just to cash in. This is the case with a popular Type 2 diabetes medication, Onglyza.
Read More
Science Supports Compulsive Behaviors in Abilify Users
It seems far-fetched. There is no way a side effect could do that. This is the sentiment for many friends and family members when they learn their loved one developed a compulsive behavior like excessive gambling while taking the prescription drug, Abilify. Unfortunately, it is true for thousands of Americans who took the drug, and
Read More
Invokana Lawsuit Update
There is a recent development in the Invokana lawsuit against the manufacturer, Janssen Pharmaceutical, a subsidiary of Johnson & Johnson. The company netted almost $1 billion in profits from Invokana in 2016 alone. The Judicial Panel on Multidistrict Litigation (JPMDL) issued an order to consolidate dozens of Invokana (canagliflozin) diabetic ketoacidosis (DKA) and kidney damage lawsuits to
Read More
Thirty Percent of Hernia Surgeries Could Have Used Faulty Hernia Mesh
Every year, 1 million people have their hernia repaired. They trust their doctors that this surgery is necessary for them to relieve their constant pain. Now, many are finding the hernia mesh used in their surgeries were rushed to market and is causing more damage than their hernia ever did. Thirty percent of hernia surgeries
Read More
Johnson & Johnson and Their Dangerous Legacy
For decades, Johnson & Johnson created a wholesome brand to appeal to the American consumer. They have tricked people into thinking their products are safe. However, more and more of their products are failing. Failing so gravely that serious harm is befalling those same innocent consumers who trusted their wholesome image. This is Michael Brady
Read More
Ethicon’s Physiomesh Flexible Composite Mesh Recall
Johnson & Johnson’s manufacturer, Ethicon issued a full recall of its Physiomesh Flexible Composite Mesh after two studies found higher rates of hernias re-opening versus similar products. What is Physiomesh Flexible Composite Mesh? Every year, surgeons perform around 150,000 ventral hernia repairs in the United States. Doctors can perform the operation laparoscopically or by opening
Read More
Ovarian Cancer Misdiagnosis Grow Along with Talcum Powder Lawsuits
This is Michael Brady Lynch, Lead Trial Attorney for The Michael Brady Lynch Firm. The Daily Mail recently reported doctors misdiagnose almost half of women with ovarian cancer. This mean to 4 in 10 patients with cancer did not have their symptoms taken seriously. Therefore, doctors did not perform the necessary ovarian cancer screenings for
Read More
FDA Updates Essure’s Warning Label Instead of Recall
After treating women as though their injuries were invalid, the FDA is finally asking Bayer, the manufacturer of Essure, to update the warning label on the dangerous permanent birth control, Essure. The new label will include warnings for the risk of implant perforation, device migration, allergic reaction, pain and other possible adverse events. The Essure
Read More
Stryker Hip Implant: The Silent Killer
This is Michael Brady Lynch, Lead Trial Attorney, for The Michael Brady Lynch Firm. Imagine going through a painful hip replacement surgery only to find out that within a few months or even a few short years, your implant is slowly killing you. Many are facing this grim reality. They are realizing the metal implant
Read MoreThe Dangers of Generic Viagra
This is Michael Brady Lynch, Lead Trial Attorney for The Michael Brady Lynch Firm. Next year, manufacturer Teva will release a generic version of the popular erectile dysfunction medication, Viagra. This will be the first time a generic form of the drug will be released in The United States. The FDA approved three different strengths of the
Read More